[Coronary thrombosis: Physiopathology and treatment in the era of tailored medicine]

Abstract

Coronary thrombosis remains the leading cause for cardiovascular death in France. Great advances have been made in the knowledge of the basic mechanism involved in coronary thrombogenesis and in antithrombotic treatments. They have led to substantial survival benefit after myocardial infarction and enabled development of tailored therapeutic strategies, especially for high-risk patients. Direct oral anticoagulants have now entered the game for secondary prevention after coronary thrombosis.

Keywords: Acute myocardial infarction; Antiplaquettaire; Antiplatelet treatment; Atherosclerosis; Athérosclérose; Coronary thrombosis; Infarctus du myocarde; Thrombose coronaire.